BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30088802)

  • 21. Lymphocyte-Specific Biomarkers Associated With Preterm Birth and Bronchopulmonary Dysplasia.
    Bhattacharya S; Mereness JA; Baran AM; Misra RS; Peterson DR; Ryan RM; Reynolds AM; Pryhuber GS; Mariani TJ
    Front Immunol; 2020; 11():563473. PubMed ID: 33552042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory and chest wall mechanics in very preterm infants.
    Stoecklin B; Veneroni C; Choi YJ; Pillow JJ; Dellacà RL
    J Appl Physiol (1985); 2024 Jun; 136(6):1499-1506. PubMed ID: 38634505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia.
    Caskey S; Gough A; Rowan S; Gillespie S; Clarke J; Riley M; Megarry J; Nicholls P; Patterson C; Halliday HL; Shields MD; McGarvey L
    Ann Am Thorac Soc; 2016 Aug; 13(8):1262-70. PubMed ID: 27222921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can infant lung function predict respiratory morbidity during the first year of life in preterm infants?
    Proietti E; Riedel T; Fuchs O; Pramana I; Singer F; Schmidt A; Kuehni C; Latzin P; Frey U
    Eur Respir J; 2014 Jun; 43(6):1642-51. PubMed ID: 24696112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early Neonatal Oxygen Exposure Predicts Pulmonary Morbidity and Functional Deficits at 1 Year.
    Dylag AM; Kopin HG; O'Reilly MA; Wang H; Davis SD; Ren CL; Pryhuber GS
    J Pediatr; 2020 Aug; 223():20-28.e2. PubMed ID: 32711747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lung function at 6 and 18 months after preterm birth in relation to severity of bronchopulmonary dysplasia.
    Thunqvist P; Gustafsson P; Norman M; Wickman M; Hallberg J
    Pediatr Pulmonol; 2015 Oct; 50(10):978-86. PubMed ID: 25187077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variability of Tidal Breathing Parameters in Preterm Infants and Associations with Respiratory Morbidity during Infancy: A Cohort Study.
    Usemann J; Suter A; Zannin E; Proietti E; Fouzas S; Schulzke S; Latzin P; Frey U;
    J Pediatr; 2019 Feb; 205():61-69.e1. PubMed ID: 30416016
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical characteristics and risk factors of very low birth weight and extremely low birth weight infants with bronchopulmonary dysplasia: multicenter retrospective analysis].
    Jiangsu Multicenter Study Collaborative Group for Breastmilk Feeding in Neonatal Intensive Care Units
    Zhonghua Er Ke Za Zhi; 2019 Jan; 57(1):33-39. PubMed ID: 30630229
    [No Abstract]   [Full Text] [Related]  

  • 30. The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization.
    Siffel C; Hirst AK; Sarda SP; Chen H; Ferber J; Kuzniewicz MW; Li DK
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10271-10278. PubMed ID: 36170979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium.
    Ryan RM; Keller RL; Poindexter BB; D'Angio CT; Shaw PA; Bellamy SL; Moore PE; McPherson C; Greenberg JM;
    J Pediatr; 2019 May; 208():148-155.e3. PubMed ID: 30857774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
    Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
    Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary function tests in extremely low gestational age infants at one year of age.
    Voynow JA; Feng R; Ren CL; Dylag AM; Kemp JS; McDowell K; Sharp J; Moore PE; Eichenwald E; Panitch H; Clem C; Johnson R; Davis SD
    Pediatr Pulmonol; 2022 Feb; 57(2):435-447. PubMed ID: 34779149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal hematological parameters and the risk of moderate-severe bronchopulmonary dysplasia in extremely premature infants.
    Chen X; Li H; Qiu X; Yang C; Walther FJ
    BMC Pediatr; 2019 Apr; 19(1):138. PubMed ID: 31039810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urine gastrin-releasing peptide in the first week correlates with bronchopulmonary dysplasia and post-prematurity respiratory disease.
    Voynow JA; Fisher K; Sunday ME; Cotten CM; Hamvas A; Hendricks-Muñoz KD; Poindexter BB; Pryhuber GS; Ren CL; Ryan RM; Sharp JK; Young SP; Zhang H; Greenberg RG; Herring AH; Davis SD
    Pediatr Pulmonol; 2020 Apr; 55(4):899-908. PubMed ID: 31995668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.
    Bell EF; Hintz SR; Hansen NI; Bann CM; Wyckoff MH; DeMauro SB; Walsh MC; Vohr BR; Stoll BJ; Carlo WA; Van Meurs KP; Rysavy MA; Patel RM; Merhar SL; Sánchez PJ; Laptook AR; Hibbs AM; Cotten CM; D'Angio CT; Winter S; Fuller J; Das A;
    JAMA; 2022 Jan; 327(3):248-263. PubMed ID: 35040888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Intermittent Hypoxemia and Severe Bronchopulmonary Dysplasia in Preterm Infants.
    Jensen EA; Whyte RK; Schmidt B; Bassler D; Vain NE; Roberts RS;
    Am J Respir Crit Care Med; 2021 Nov; 204(10):1192-1199. PubMed ID: 34428130
    [No Abstract]   [Full Text] [Related]  

  • 38. Longitudinal assessment of the lung mechanics of very low birth weight preterm infants with and without bronchopulmonary dysplasia.
    Mello RR; Silva KS; Costa AM; Ramos JR
    Sao Paulo Med J; 2015; 133(5):401-7. PubMed ID: 26648428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital outcomes of premature infants with severe bronchopulmonary dysplasia.
    Jackson W; Hornik CP; Messina JA; Guglielmo K; Watwe A; Delancy G; Valdez A; MacArthur T; Peter-Wohl S; Smith PB; Tolia VN; Laughon MM
    J Perinatol; 2017 Jul; 37(7):853-856. PubMed ID: 28383537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratracheal budesonide mixed with surfactant to increase survival free of bronchopulmonary dysplasia in extremely preterm infants: study protocol for the international, multicenter, randomized PLUSS trial.
    Manley BJ; Kamlin COF; Donath S; Huang L; Birch P; Cheong JLY; Dargaville PA; Dawson JA; Doyle LW; Jacobs SE; Wilson R; Davis PG; McKinlay CJD
    Trials; 2023 May; 24(1):320. PubMed ID: 37161488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.